XML 52 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Business Combination - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 15, 2020
shares
Sep. 15, 2020
shares
Apr. 28, 2020
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Business Acquisition [Line Items]              
Reverse stock split exchange ratio   0.1240          
Percentage of outstanding capital stock 75.00% 75.00%          
Reverse stock split 1-for-7 1-for-7          
Goodwill       $ 20,739   $ 20,739  
Transition Agreement [Member]              
Business Acquisition [Line Items]              
Amount equal to pro-rated bonus     $ 212,000        
Lump sum payable     250,000        
Payable upon closing of merger     24,000        
Legal fees     15,000        
Advisory services annual fee     12,500        
resTORbio              
Business Acquisition [Line Items]              
Reverse stock split exchange ratio   0.1240          
Number of shares of surviving stock options | shares   81,370          
Unvested restricted stock units outstanding | shares 91,309 91,309          
Common stock share issued on a net settlement basis | shares   55,854          
Goodwill       20,739   20,739  
Transaction cost for merger       2,100   7,100  
Transaction cost for business acquisition       $ 8,600 $ 8,600 $ 15,600 $ 15,600
resTORbio | Transition Agreement [Member]              
Business Acquisition [Line Items]              
Cash payment     $ 470,000        
Expiration period closing of the merger     60 days        
resTORbio | Common Stock              
Business Acquisition [Line Items]              
Percentage of outstanding capital stock 25.00% 25.00%